Cargando…
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
PURPOSE: We have previously demonstrated in a pilot study of 348 invasive breast cancers that mast cell (MC) infiltrates within primary breast cancers are associated with a good prognosis. Our aim was to verify this finding in a larger cohort of invasive breast cancer patients and examine the relati...
Autores principales: | Rajput, Ashish B., Turbin, Dmitry A., Cheang, Maggie CU, Voduc, David K., Leung, Sam, Gelmon, Karen A., Gilks, C. Blake, Huntsman, David G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2137942/ https://www.ncbi.nlm.nih.gov/pubmed/17431762 http://dx.doi.org/10.1007/s10549-007-9546-3 |
Ejemplares similares
-
Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis
por: Turashvili, Gulisa, et al.
Publicado: (2009) -
4444 The effect of early life antibiotics on gut microbiome and fecal bile acid concentrations in children
por: Benitez, Alain Jesus, et al.
Publicado: (2020) -
The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer
por: El Ansari, Rokaya, et al.
Publicado: (2020) -
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
por: Habibi, Golareh, et al.
Publicado: (2008) -
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma
por: Prentice, Leah M, et al.
Publicado: (2007)